Stock ESTA ESTABLISHMENT LABS HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Establishment Labs Holdings Inc.

Equities

ESTA

VGG312491084

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
48.47 USD -0.14% Intraday chart for Establishment Labs Holdings Inc. +2.30% +87.22%
Apr. 03 Citigroup Raises Price Target on Establishment Labs to $60 From $49, Maintains Buy Rating MT
Apr. 02 Establishment Labs Says US FDA Schedules Preapproval Inspection of Motiva Implants Facility MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Establishment Labs to Announce First Quarter 2024 Financial Results on May 8
BU
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
BU
Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
BU
ESTABLISHMENT LABS ANNOUNCES PARTICIPATION IN TWO UPCOMING INVESTMENT CONFERENCES
AQ
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
BU
Establishment Labs Announces Amended Credit Facility with Oaktree
BU
Establishment Labs to Announce Fourth Quarter 2023 Financial Results on February 28
BU
Establishment Labs Announces Commercial Launch of Motiva Implants in China
BU
Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023
BU
Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander
BU
Establishment Labs to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BU
ESTABLISHMENT LABS ANNOUNCES PARTICIPATION IN TWO UPCOMING INVESTMENT CONFERENCES
AQ
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
BU
Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China
BU
Establishment Labs Reports Third Quarter 2023 Financial Results
BU
Establishment Labs to Announce Third Quarter 2023 Financial Results on November 7
BU
ESTABLISHMENT LABS ANNOUNCES TWO-YEAR MIA FEMTECH CLINICAL RESULTS AND THE LAUNCH OF ZEN AT 8TH WORLD SYMPOSIUM ON ERGONOMIC IMPLANTS
AQ
Establishment Labs Announces FDA Clearance of Motiva Flora SmoothSilk Tissue Expander
BU
Establishment Labs Announces Two-Year Mia Femtech Clinical Results and the Launch of Zen at 8th World Symposium on Ergonomic Implants
BU
Establishment Labs Reports Record Second Quarter 2023 Financial Results
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ESTA Stock
  4. News Establishment Labs Holdings Inc.
  5. Press Releases